or
forgot password
  • cancer clinical trials in mason city, IA

  • Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Breast Cancer
    Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Lung Cancer
    Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Breast Cancer
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Breast Cancer
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Lymphoma
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Creatine in Treating Patients With Cancer-Associated Weight Loss
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Anorexia, Cachexia, Unspecified Adult Solid Tumor, Protocol Specific, Weight Changes
    Ixabepilone in Treating Patients With Metastatic Prostate Cancer
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Prostate Cancer
    CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
    Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Recurrent Mantle Cell Lymphoma
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    S-1 as Second-Line Therapy in Treating Patients With Unresectable or Recurrent Stage III or Stage IV Non-Small Cell Lung Cancer
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Lung Cancer
    S-1 as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Pancreatic Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Colorectal Cancer
    Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Breast Cancer, Cognitive/Functional Effects, Colorectal Cancer, Lung Cancer, Pain, Prostate Cancer, Psychosocial Effects of Cancer and Its Treatment
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma
    Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Prostate Cancer
    Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
    Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Esophageal Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Evaluation of Programs of Coordinated Care and Disease Management
    Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Congestive Heart Failure, Diabetes, Coronary Artery Disease, Chronic Obstructive Pulmonary Disease, Cancer, Cerebrovascular Disease, Alzheimer's Disease, Psychotic Disorder, Major Depression
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Esophageal Cancer
    Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
    Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Lymphoma
    Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Endometrial Cancer, Fatigue, Neurotoxicity
    Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
    Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer, Stage IV Rectal Cancer
    Acute Pain Caused by Paclitaxel in Patients With Cancer
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Chemotherapeutic Agent Toxicity, Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Breast Cancer, Lung Cancer, Metastatic Cancer, Multiple Myeloma, Plasma Cell Neoplasm, Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Brain and Central Nervous System Tumors
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Lung Cancer
    Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Melanoma (Skin)
    Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Brain and Central Nervous System Tumors, Neurotoxicity
    Home-Based Programs for Improving Sleep in Cancer Survivors
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Cancer Survivor, Fatigue, Psychosocial Effects of Cancer and Its Treatment, Sleep Disorders
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Colorectal Cancer, Precancerous Condition
    Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Leukemia
    Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Recurrent Esophageal Cancer, Squamous Cell Carcinoma of the Esophagus, Stage IV Esophageal Cancer
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
    N. Iowa Mercy Cancer Center
    Mason City, Iowa 50401
    Chronic Myeloid Leukemia
    Magnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast Cancer
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Breast Cancer, Cancer Survivor, Hot Flashes
    Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
    Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer
    Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
    Mercy Cancer Center
    Mason City, Iowa 50401
    Colorectal Cancer
    Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Anal Cancer
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Breast Cancer
    Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Leukemia
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Drug/Agent Toxicity by Tissue/Organ, Lung Cancer, Radiation Toxicity
    Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Hot Flashes, Prostate Cancer
    Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Kidney Cancer
    Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Osteoporosis, Prostate Cancer
    S0124: Cisplatin Combined With Either Irinotecan or Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Lung Cancer
    EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Breast Cancer, Neurotoxicity
    Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Colorectal Cancer, Metastatic Cancer
    Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer
    Mercy Cancer Center at Mercy Medical Center - North Iowa
    Mason City, Iowa 50401
    Pancreatic Cancer